Cyclacel Pharmaceuticals (CYCC) executive Schwartz received 12,500 shares
Insider transactions reported
Brian Schwartz (Interim Chief Medical Officer at Cyclacel Pharmaceuticals Inc., CYCC) reported that they received 12,500 shares on Jan 29, 2024. After these transactions the filing shows 15,205 shares held directly.
- Reporting person
- Schwartz Brian
- Role
- Interim Chief Medical Officer
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jan 29, 2024 | Grant or award (A) | Common Stock1, 2 | +12,500 | - | - | 15,205 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jan 29, 2024 | Grant or award (A) | Stock Option (right to buy)On 12,500 Common Stock2, 3 | +12,500 | - | - | 12,500 direct |
Holdings before and after
- Common Stock: 2,705 to 15,205 direct
- Stock Option (right to buy): 0 to 12,500 direct
Footnotes from the filing
- 1. Consists of restricted stock units ( RSUs ). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal monthly installments beginning on February 29, 2024, subject to the Reporting Person's continued service through the applicable vesting date.
- 2. These securities were granted to Dr. Schwartz in connection with his appointment as interim Chief Medical Officer of Cyclacel Pharmaceuticals, Inc.
- 3. The shares underlying the option vest in equal monthly installments beginning on February 29, 2024, subject to the Reporting Person's continued service through the applicable vesting date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Schwartz report in this CYCC Form 4?
Brian Schwartz (Interim Chief Medical Officer at Cyclacel Pharmaceuticals Inc., CYCC) reported that they received 12,500 shares on Jan 29, 2024. After these transactions the filing shows 15,205 shares held directly.
How many CYCC shares does Schwartz hold after this filing?
The filing shows 15,205 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for CYCC
Earlier insider filings at CYCC
- Dec 26, 2023Rombotis Spiro George bought $20,122 worth of shares (6,070 units at $3.31), increasing direct ownership by 10% to 68,658 units (SEC Form 4)
- Dec 26, 2023Mcbarron Paul bought $6,252 worth of shares (1,886 units at $3.31), increasing direct ownership by 6% to 33,378 units (SEC Form 4)
- Jul 3, 2023SEC Form 4 filed by Rombotis Spiro George
- Jul 3, 2023SEC Form 4 filed by Barker Sam L
- Jul 3, 2023SEC Form 4 filed by Spiegel Robert J.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Follow CYCC and get a push notification the moment its next story breaks.